Reuters logo
BRIEF-GSK says submits US application for malaria drug
November 28, 2017 / 10:22 AM / 13 days ago

BRIEF-GSK says submits US application for malaria drug

Nov 28 (Reuters) - GLAXOSMITHKLINE PLC:

* ‍SUBMITS US REGULATORY APPLICATION FOR SINGLE-DOSE TAFENOQUINE FOR PLASMODIUM VIVAX MALARIA​

* GSK.L - ‍TAFENOQUINE IS NOT APPROVED FOR USE ANYWHERE IN WORLD; PLANS TO PROGRESS REGULATORY FILINGS IN OTHER COUNTRIES IN 2017 AND 2018​ Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below